E Sreekumar

RGCB, Thiruvananthapuram

Dr Sreekumar is a Senior Scientist at the Molecular Virology Laboratory, BRIC-Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, and a former Director of the Institute of Advanced Virology, Kerala. He holds an MVSc in Immunology from IVRI and a PhD in Biotechnology from RGCB. He has 22 years of research experience, and his expertise spans emerging viruses, particularly dengue, chikungunya, rabies, and Nipah, host–virus interactions, and antiviral development. As Director of IAV, he played a pivotal role in establishing 14 BSL-2 research laboratories, initiating research and academic programmes, and molecular diagnostic services, elevating the institute to national prominence. He has served on key national and international advisory bodies, including WHO’s Diagnostic and Technical Advisory Group (DTAG) and State expert committees on COVID-19 and Rabies. He is a recipient of the Fulbright-Nehru Academic and Professional Excellence Fellowship and has served as Visiting Faculty at Johns Hopkins University, USA.

E Sreekumar

2C- Special Session on Public Health

Chairperson: Saumitra Das, IISc, Bengaluru

From Endemic Rabies to Emerging Nipah in Kerala: E2E Preparedness through Translational Virology

Implementation of virology research with goal-oriented approaches and short-term translational focus has become imperative for the country, which is witnessing increased emergence and re-emergence of viral infections. Rabies, a classic disease causing vaccine- preventable deaths, continues as a major One-health concern. Endemic diseases like dengue and other mosquito-borne infections have no available treatment or effective vaccines. Emergence of newer and fatal infections such as Nipah presents new demands on infectious disease research. While the challenges posed by these disease categories remain distinct, there is a common pressing need for concerted research efforts and stress on developing end-to-end (E2E) solutions indigenously. For tangible outcomes, fragmented research activities focusing on theoretically-perceived problems should give way to mission-mode efforts on clinical priorities with clear translation potential. The talk explores a bed-to-bench- to-bed (B2B2B) approach to address clinical priorities, accelerate translational outcomes and bridge the gap between research and patient care.

© 2026 Indian Academy of Sciences, Bengaluru.